Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Other financing activities (2016 - 2025)

Historic Other financing activities for Integra Lifesciences Holdings (IART) over the last 14 years, with Q3 2025 value amounting to $75000.0.

  • Integra Lifesciences Holdings' Other financing activities changed N/A to $75000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $75000.0, marking a year-over-year decrease of 7508.31%. This contributed to the annual value of $7.9 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Other financing activities is $75000.0.
  • Over the past 5 years, Integra Lifesciences Holdings' Other financing activities peaked at $7.6 million during Q1 2023, and registered a low of $75000.0 during Q3 2025.
  • Over the past 3 years, Integra Lifesciences Holdings' median Other financing activities value was $275000.0 (recorded in 2021), while the average stood at $2.1 million.